Antihemostatic, antiinflammatory, and immunosuppressive properties of the saliva of a tick, Ixodes dammini by unknown
ANTIHEMOSTATIC,  ANTIINFLAMMATORY,  AND 
IMMUNOSUPPRESSIVE  PROPERTIES  OF  THE  SALIVA  OF 
TICK,  IXODES  DAMMINI 
A 
BY  J.  M.  C.  RIBEIRO,  G.  T.  MAKOUL*,  J.  LEVINE,  D.  R.  ROBINSON*  AND 
A. SPIELMAN 
From the Department of Tropical Public Health, Harvard School of Public Health, and the 
* Department of Medicine Harvard Medical School, and The Arthritis Unit, Massachusetts 
General Hospital Boston, Massachusetts 02115 
Hematophagous organisms must overcome host hemostasis in order to locate 
blood and maintain its flow during ingestion (1, 2). Platelet aggregation provides 
the main hemostatic obstacle because duration of bleeding of lacerated small 
vessels depends mainly upon platelet function (3, 4). Important stimuli inducing 
platelet  aggregation  include ADP  (released by  injured cells),  collagen  fibrils 
(exposed in subendotheliai tissues),  thrombin (produced after activation of the 
coagulation cascade) and PAF I (platelet-aggregating factor, released by leuko- 
cytes). Activated platelets may release thromboxane A2 (a potent vasoconstrictor 
and platelet-aggregating stimulus), ADP, and serotonin (which further enhance 
platelet aggregation and  vessel  constriction) (5).  In addition,  platelet-derived 
factors will also contribute to thrombin formation and clotting, thus providing 
rigidity to the platelet plug (4). Thus, one can anticipate that any antihemostatic 
properties of blood-feeding arthropods will focus mainly on platelet aggregation 
and, secondarily, on vascular contraction or coagulation. 
Hard ticks feed solely on blood, each engorgement generally extending over 
at least several days, thereby providing ample time for inflammation to promote 
hemostasis at the feeding site, while increasing the tick's need to antagonize this 
process. Leukocyte-derived products, particularly PAF, would enhance hemosta- 
sis at  the point of tick attachment.  Immune mechanisms may further reduce 
feeding success by enhancing inflammatory reactions (6, 7). Interestingly, saliva 
of  some  ticks  includes  an  anticoagulant,  an  antihistamine,  and  prostaglan- 
dins(PG);  these compounds may facilitate feeding (8). Other enzymes, including 
esterases  and  glycosidases  have  been  identified,  but  their  functions  remain 
unknown (8). Antiplatelet activity, however, has not been described. 
Their prolonged period of contact with a narrow range of hosts suggests that 
hard ticks may possess effective antihemostatic mechanisms peculiarly adapted 
to interfere with the inflammatory mechanisms of particular hosts. Accordingly, 
we sought to describe the salivary armamentarium of such a tick, and to ascribe 
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function  to  its  various  components.  In  particular,  we  attempted  to  identify 
platelet antiaggregating activity, as well as antiinflammatory components in saliva 
harvested from Ixodes dammini. 
Materials and Methods 
Materials.  PG were kindly provided by Dr. J. E. Pike (Upjohn Co. Kalamazoo, MI). 
Glucose  and  inorganic  salts  used  were  American  Chemical  Society-standard.  Other 
reagents were obtained from Sigma Chemical Co., St. Louis, MO. Anti-Thy-1 monoclonal 
antibody (mAb) was kindly provided by Dr. Ethan Shevach (Laboratory of Immunology, 
National Institutes of Health (9). 
Source of Ticks.  Adult I. dammini ticks were collected by flagging on Great Island, in 
West Yarmouth on Cape Cod in southern Massachusetts, during the spring of 1984. 
Harvest of Saliva.  Piiocarpine was used to induce ticks to salivate (10, 11). Ticks were 
permitted to engorge for 4-5 d on the ear of a rabbit, after which they were removed by 
traction. Ticks weighed 25-175 mg. To collect saliva,  1 #1 of a  5%  (wt/vol) pilocarpine 
hydrochloride solution in 0.7 M NaCI was injected through glass micropipettes near the 
corner of the scutum while the ticks were restrained on glass  slides  by adhesive tape. 
Saliva  was  collected in  glass  tubes throughout  2  h  postinjection at  35°C  in  a  humid 
chamber.  1-25 mg of saliva were collected per tick, and samples were stored at -27°C. 
Collections <3 mg were pooled until ___ 3 mg was obtained. <5% of samples were small 
enough to require such pooling. 
Platelet Aggregation.  Platelet aggregation was monitored in an aggregometer equipped 
with a  0.1  ml cuvette (12,  13)  using human  citrated platelet-rich plasma  (0.38%  final 
citrate). Five or more saliva samples were pooled for each experiment. 
Smooth Muscle  Bioassay.  Superfused rat stomach strips were prepared as previously 
described (14), but using aerated Tyrode's solution (15). In some experiments, laminar 
flow  superfusion  was  used  (14).  Antagonists  added  to  the  perfusion  fluid  included: 
methysergide maleate (2 x  10  -7 g/ml), mepyramine hydrochloride (10  -7 g/ml), phenox- 
ybenzamine hydrochloride (10-! g/ml), propanolol hydrochloride (2 x  10  -6 g/ml), hyos- 
cine hydrobromide (10 -7 g/ml), and indomethacin (2 X 10  -6 g/ml). Superfusion was done 
either at 2.0 ml/min or 0.15 ml/min (laminar flow superfusion mode) at 30°C, because 
we observed maximum  sensitivity of preparations at  this temperature.  The perfusion 
liquid, delivered through a microperpex peristaltic pump (LKB Instruments, Inc., Gaith- 
ersburg, MD), was interrupted for 10 s when standards or individual saliva samples were 
added. Such samples (---5 #1) were added in 0.1-ml aliquots dissolved in Tyrode's solution. 
Isometric contractions were  recorded  using  a  Harvard  isotonic/isometric transducer. 
Guinea pig ileum preparations were prepared using a 5 ml bath (15). 
Clotting  Assays.  Recalcification time was determined by incubating 50 #1 of citrated 
human plasma with 0.15 M NaCI in  1 x  7 cm glass tubes (16). After 1 min at 37°C, 50 
el of CaCI2 were added, and tubes then inspected for clotting every 10 s. Tick saliva (2.5 
#l  from individual samples) was  added with  the  NaCI  solution, when appropriate. To 
determine prothrombin time (17), human citrated plasma, in 50-#1 samples, was incubated 
for 1 min at 37°C, and  100 #1 of a thromboplastin (Sigma Chemical Co.) -CaCI~ (12.5 
mM)  mixture  was  added  to  the  plasma.  Clotting  was  followed by  shaking  the  tube 
continuously on the surface of a water bath. Tick saliva (2.5 #i) or 0.15 M NaC1 solutions 
were added to the plasma, when appropriate. 
Apyrase Determination.  Apyrase activity was identified by measuring orthophosphate 
release (18) from ATP, ADP, or AMP in a reaction medium containing 50 mM Tris HC1, 
pH 7.5, 100 mM NaCi, 5 mM MgCI~, 2 mM nucleotide, and 1 #1 of tick saliva, in a final 
volume of 0.1  ml.  Reactions proceeded for 30 min at 37°C, and were stopped by the 
addition of acid molybdate reagent.  1 U of enzymatic activity represents the amount of 
enzyme that produces orthophosphate at 1 #mol/min at 37°C, at the specified reaction 
mixture. 
PGE2 Radioimmunoassay  (RIA).  RIA for PGE~ was performed as described previously 
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Production and Assay of T Cell Hybridomas.  The T  hybridomas (E8.A 1) used in these 
experiments were produced by fusing  sheep insulin-primed  lymph node cells with the 
BW 5147 AKR thymoma (20). This cell line is an autoreactive I-Ak-specific T  cell. To 
assay activity, T  hybridoma cells (105 cells/well) were cultured with anti-Thy-1  (I:1000 
dilution)  in complete medium (RPMI  1640 containing  8% fetal calf serum,  300 #g]ml 
penicillin, 50 #M 2-mercaptoethanol, and 10 mM Hepes buffer). Cells were cultured both 
in the presence and absence of tick saliva. Samples of saliva, ranging from 6 to 20 #1 were 
diluted to 0.2 ml, and  1 #1 of this diluted saliva was added to each well, to a 200 #1 total 
volume per well. After incubating for 24 h at  37°C, supernatants  were collected and 
assayed for interleukin (IL-2) content in a secondary culture using IL-2-dependent T cell 
line HT-2 (4 ×  103 cells/100 #l/well).  HT-2 cells were cultured for 24 h at 370C in the 
presence of 60 #i primary culture supernatants.  1 #C of [SH]thymidine (6.8  Ci]nmol; 
Amersham Corp., Arlington  Heights, IL) was added to each well, and cells were harvested 
after 16-24 h incubation on a miniMASH  II (M. A. Bioproducts, Walkersville, MD). The 
degree of stimulation  was measured by the amount of radioactivity  retained by the glass 
fiber filter, as determined by liquid scintilation counting. 
Plasma Bradykinin Generation.  Plasma bradykinin  was generated by adding 25 #1 of a 
4% (wt/vol) kaolin suspension in 0.15 M NaCi to 100 #1 of human citrated, platelet-poor 
plasma  (21). After  1 rain  at  37°C,  the  mixture  was added  to  the  guinea  pig  ileum 
preparation. 
Results 
Platelet Antiaggregating Activity.  To detect platelet antiaggregating activity, 4 
~1 of tick saliva were added to  100 #1 of citrated human plateletorich plasma in 
an  aggregometer  cuvette.  Platelet aggregation  was triggered  by adding  ADP, 
collagen suspension, or PAF, all used in concentrations that triggered maximum 
platelet response. A minor and transient episode of platelet aggregatioo followed 
addition of saliva to the platelet-rich  plasma (Figs.  1-3), but subsequent aggre- 
gation was aborted or delayed. We conclude that the saliva of this tick contains 
antiplatelet activity that is effective against the main stimuli of platelet aggrega- 
tion anticipated at the tick's feeding site. 
Anticoagulant Activity.  Because coagulation not only consolidates the already 
formed  platelet  plug,  but  contributes  to  its  formation  by promoting  platelet 
aggregation  (4-5),  we  sought  evidence of an  anticoagulant  in  the  tick  saliva. 
First,  we determined  whether  saliva  may delay recalcification  time of citrated 
human plasma. Samples that normally clotted in 88 +  1 s, clotted in  131  _+ 10 s 
when 2.5 t~i of saliva were added (k _+ SE; n =  6; P <  0.01, paired t test). Addition 
of saliva did not affect prothrombin  time. Because this assay depends on factors 
VII,  X,  and  thrombin  as  well  as  fibrinogen,  we  conclude  that  saliva  delays 
coagulation by acting on the intrinsic pathway of the coagulation cascade before 
factor X  activation.  This activity may help prevent coagulation and  thrombin 
formation at the feeding site. 
Apyrase Activity.  Apyrase enzymes have recently been described in the saliva 
of blood-sucking bugs (26),  tse-tse flies (28),  and  mosquitoes (29),  where  they 
account, at least in part, for the anti-platelet-aggregating properties of the saliva 
of these unrelated blood-feeding insects.  Accordingly, we investigated whether 
L  dammini  may have evolved a  similar  antiplatelet  system.  Indeed,  tick  saliva 
hydrolyzed both ATP and ADP (Table I), but not AMP (not shown), and this 
characterizes apyrase activity. When estimating this activity, provision was made 
for  the  presence  of  2.5  +  0.3  mM  orthophosphate  (n  =  10)  in  the  saliva. RIBEIRO  ET  AL.  335 
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FIGURE  1.  Inhibition of ADP-induced platelet aggregation by tick saliva. Platelet-richplasma 
(100 ~I) was preincubated for 1 min with continuous stirring. At the beginning of the tracings, 
saline (control) or saliva was added (4 ~1). The arrow marks the addition of ADP (2 ~M final 
concentration). 
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FIGURE 2.  Inhibition of collagen-induced platelet aggregation by tick saliva. Other conditions 
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FIGURE 3.  Inhibition  of PAF-acether-induced platelet  aggregation  by  tick  saliva.  Final 
concentration of PAF was 50 ng/ml. Other conditions as in Fig.  1. 
TABLE  I 
Apyrase Activity in Samples of Saliva Individually Harvested  From 
Adult, Female Ixodes dammini Stimulated by Pilocarpine 
Sample number 
Activity with substrate* 
ATP  ADP 
1  0.36  0,33 
2  0.11  0,12 
3  1.84  1.48 
4  0.12  0,11 
5  0.25  0.24 
6  0.75  O.6O 
7  0.67  0.71 
8  2.95  2.39 
9  0.28  0.26 
10  1.66  1.47 
_+ SE:  0.90 _+ 0.30  0.77 +  0.24 
* Expressed as  micromoles of orthophosphate released per minute per 
milliliter of tick saliva at 37°C. RIBEIRO  ET  AL.  337 
Preliminary characterization of this enzyme activity in pooled saliva indicated a 
requirement for divalent cations, and that Mg  ++ was a better activator than Ca  ++. 
Optimum pH was 8.5-9.0 both for ATP and ADP hydrolysis, and both activities 
were  stimulated  by  20  mM  2-mercaptoethanol.  The  ratio  of ATP  to ADP 
hydrolysis at  pH  7.5  was  1.10  __.  0.04  to  1  (n  --  10),  demonstrating  close 
correlation between the two hydrolytic activities, despite a broad range of activity 
when individual samples were compared (Table I). We conclude that tick saliva 
contains an enzyme with apyrase activity. 
PGE2 Characterization.  Anti-platelet-aggregating activity seemed too great to 
be  explained  solely  by  apyrase,  particularly the  powerful inhibition  of PAF- 
induced platelet aggregation (Fig. 3) (5). Substances that increase platelet cyclic 
AMP are good inhibitors of PAF-induced platelet aggregation (5),  and among 
these are PG of the E series and prostacyclin (5).  Evidence of salivary PG was 
then sought by means of a  rat stomach strip bioassay. The tissue was rendered 
insensitive to most agonists by antagonists administered in the perfusion solution. 
Piiocarpine solutions, similar to that used to stimulate ticks to salivate, did not 
induce contractions. Saliva, on the other hand, induced contractions having an 
activity equivalent to  94  _  32  ng PGE2/ml of saliva  (n =  9) (Figs.  4  and  5), 
thereby suggesting the presence of PG in tick saliva. 
RIA of the same samples used in the bioassay, demonstrated the presence of 
97  +  36  ng PGE2/ml of saliva.  When compared individually, the bioassay and 
RIA results correlated closely (correlation coefficient, 0.974)  (Fig.  5) and the 
slope of the regression line (0.88) did not differ from unity (as shown by analysis 
of variance). This suggests that most, if not all, rat fundus-contracting activity 
can be attributed to PGE2. 
Immunosuppressive Activity.  Because  PGE~  is  immunosuppressive  (23),  we 
asked  whether tick  saliva  inhibits  T  lymphocyte activation.  In  this  system, a 
cloned T  cell hybridoma, ES.A 1 was activated by the anti-Thy-1 mAb to secrete 
IL-2. The presence of IL-2 in conditioned media from E8.A1  cells was deter- 
PGE=  2  5  2  'T  5 
Saliva 
FIGURE 4.  Rat stomach strip-contracting activity induced by tick saliva. PGE, standards of 
2 and 5 ng were added as indicated. Tick saliva addition marked by arrow. 338  PROPERTIES  OF  TICK  SALIVA 
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FIGUaE  5.  Rat  stomach strip (RSS)-contracting activity and  PGE2  RIA of nine individual 
samples of tick saliva,  both expressed in nanograms of PGE2/ml of tick saliva.  The line was 
obtained by linear regression. 
TABLE  II 
Effect of Tick Saliva on the Production of lL-2 by ES.A1  T Hybridoma Cells 
Stimulated by Anti-Thy-1 mAb as Detected by [SH]Thymidine Uptake by IL-2- 
dependent Cells 
Sample  Treatment  Saliva*  PGE2*  [SH]Thymidine  Inhibition 
number  uptake 
ul/ml  pM  cpm  % 
--  None  --  --  17,804  -- 
11  Saliva  0.57  160  798  95 
12  Saliva  0.26  77  2,644  85 
13  Saliva  0.23  350  2,612  85 
14  Saliva  0.15  79  11,071  38 
* Microliters of tick saliva  per milliliter of culture during E8.A1  incubation with anti- 
Thy-1 mAb. 
* Calculated concentration of PGE~ during E8.A1 incubation, as estimated from RIA. 
mined in secondary culture, by measuring uptake of [~H]thymidine in an IL-2- 
dependent cell  line.  Suppression  of [3H]thymidine uptake  in  this  experiment 
reflected inhibition of IL-2 secretion, a consequence of inhibited T cell activation. 
The results (Table II) show that addition of <1 #1 of saliva from four individual 
ticks caused  marked suppression of IL-2  secretion by  the T  cell  hybridomas. 
Although accurate quantitative comparisons cannot be made on the basis of this 
data, the degree of suppression of IL-2 secretion is in the general range expected 
from  the  measured  quantities  of  PGE~  in  these  saliva  specimens  (38).  We 
tentatively conclude that the suppression of IL-2 production by tick saliva can 
be accounted for by their content of PGE2. 
Kininase Activity.  PGE2 is hyperalgesic, increasing the sensitivity of a lesion to 
the pain-producing effects of bradykinin (24),  which would stimulate hosts to 
remove ticks. PGE2 also potentiates the edema promoted by histamine, serotonin, 
and bradykinin (25), a reaction that is present in lesions of hosts resistant to ticks 
(32).  But ticks feed successfully and without causing pain, possibly because tick 
saliva antagonizes bradykinin. To test this hypothesis, we used a guinea pig ileum 
assay to determine whether saliva prevented bradykinin activity that was elicited RIBEIRO  ET  AL.  339 
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FIGURE 6.  Tick saliva prevention of contractures induced in guinea pig ileum by contact- 
activated, human citrated plasma. Bradykinin (BK) standards were added to the organ bath to 
give 0.5 or 1 ng/ml of the peptide, where indicated. 
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FIGURE 7.  Kininase activity of tick saliva. 50 #1 of a  1:200 dilution of tick saliva were mixed 
with 50 /~1 of bradykinin  (100 #g/ml) in Tyrode's solution and  incubated at  37°C.  At the 
indicated  time  intervals  in  minutes,  10-#1 aliquots  were  added  to  the  guinea  pig  ileum 
preparation. 
by contact activation of human plasma (21).  In effect,  1 #1 of saliva prevented 
contractions brought on by the addition of 0.1  ml of citrated plasma plus kaolin 
to the preparation  (Fig.  6).  This  effect is  consistent with that  of a  kininase, 
because, in another demonstration, bradykinin incubated in Tyrode's solution 
became progressively inactivated in the presence of saliva (Fig. 7). Such activity 
was destroyed by heat (100 °C for 1 min), and abolished in the presence of EDTA 
(3 mM), cysteine (3 mM), Zn  ++ (0.25  mM), or Co  ++ (3 mM).  The presence of 
this  kininase  in  tick  saliva  resolves  the  paradox  presented  by  the  otherwise 
hyperalgesia- and edema-promoting activities of PGE2. 
Discussion 
Saliva ejected by adult I.  dammini contains antihemostatic, antiinflammatory, 
and immunosuppressive components, properties that appear to facilitate blood~ 
feeding success of this tick during its prolonged period of host attachment. This 340  PROPERTIES  OF  TICK  SALIVA 
combination of pharmacologically active attributes of saliva in ticks are described 
for the first time. 
Piatelet  antiaggregating  activity  has  previously  been  described  for  blood- 
sucking bugs (27), tsetse flies (28), and mosquitoes (2, 29) and is here reported 
for the first time in the saliva of a tick. Indeed, L dammini saliva inhibits platelet 
aggregation induced by ADP, collagen, or PAF (Figs.  1-3), thus counteracting 
the  main  expected  stimuli  of platelet  aggregation  at  the  tick's  feeding  site. 
Thrombin formation, a  similarly anticipated factor,  is prevented by a  salivary 
anticoagulant. L dammini,  thus, is well equipped to prevent host hemostasis. 
The crucial role of ADP in aggregating vertebrate platelets (5, 30, 31), and a 
common requirement  for  blocking host hemostasis,  must have  promoted the 
apparently convergent development of salivary apyrase enzymes in such distantly 
related  arthropods  as  the  mosquito Aedes aegypti (29),  the  blood-sucking bug 
Rhodnius  prolixus  (26),  the  tse-tse  fly Glossina tachinoides (28),  and  the tick L 
dammini.  The observed apyrase  activity may account, at  least in part,  for the 
inhibitory effect of saliva on platelet aggregation. Because platelet aggregation 
is redundantly stimulated (4,  5),  effective prevention of hemostasis requires a 
redundant pharmacological cocktail.  PGE2 (22), and possibly other as yet uni- 
dentified components, may contribute to the inhibitory effect of saliva on platelet 
aggregation. 
Salivary apyrase  may promote other effects important to a  tick's  successful 
feeding. In addition to inhibiting hemostasis by degrading ADP, salivary apyrase 
may prevent those inflammatory processes stimulated by ATP (34),  including 
mast cell degranulation (35), and aggregation of neutrophils (36).  These proc- 
esses are associated with release of prohemostatic compounds such as thrombox- 
ane, PAF, and vasoactive amines (33). Apyrase converts ATP to AMP, which is 
pharmacologically inactive or even  inhibitory to purinergic  P2 receptors (37). 
Thus, apyrase contributes to antiinflammatory as well as antihemostatic activity. 
The cardinal  signs of inflammation, erythema,  edema, and  pain,  each  may 
affect the outcome of a tick's attempt to draw blood from its host. The erythem- 
atous reaction  would help by increasing the flow of blood to the feeding site 
(8,32). Edema, on the other hand, reduces blood flow or induces bleb formation, 
as in the skin of cattle resistant  to Boophilus microplus,  but not in succeptible 
animals (32). Pain, which focuses attention of the host on the parasite's feeding 
site, would increase grooming behavior.  Because inflammation both helps and 
hinders feeding, ticks may modulate inflammation selectively. 
One salivary component, PGE~, presents a  particular problem in this regard 
by producing a spectrum of effects that may hinder as well as help feeding. The 
helpful category includes erythema (increasing the flow of blood to the feeding 
tick),  inhibition  of mast  cell  degranulation  (which  helps  minimize release  of 
platelet-aggregating,  edema-promoting, and  vasoconstrictive factors) (33),  and 
immunosupression  (23)  (potentially  preventing  the  production  of antibodies 
against salivary antigens).  On the other hand, PGE2 potentiates pain produced 
by bradykinin (24), as well as edema caused by substrates that increase vascular 
permeability (25). The tick's salivary kininase may counteract these "undesirable" 
PGE~  side effects by  destroying bradykinin.  In  this  manner,  ticks antagonize RIBEIRO  ET  AL.  341 
their  host's  hemostatic and  inflammatory responses  by  the  actions of several 
distinct salivary components. 
We found that I.  dammini saliva is immunosuppressive, as measured by inhi- 
bition of T  hybridoma activation. This inhibitory activity can be explained by 
the PGE2 content of saliva, although detailed quantitative studies have not yet 
been performed. This evidence may provide an explanation for the failure of 
salivary  vaccines  to  induce  host  resistance  to  ticks  (39),  the  poor  mitogen 
responsiveness  of  T  cells  from  tick-infected  hosts  (40),  and  the  frequently 
described immunosuppressed state  of tick-infected animals (7).  Indeed, T  cell 
activation occurs at the very beginning of the cascade of cellular events leading 
to antibody production, acting at the site where the antigen is deposited (41). 
This action of tick saliva may delay, reduce, or abolish the host's response to the 
tick's salivary antigens, thus reducing immune-mediated inflammatory responses 
at the tick's feeding site. 
Tick-resistant  hosts reject  feeding ticks by  means of immune-mediated, im- 
mediate inflammatory skin reactions (6,  7).  In nature,  however, ticks are  not 
rejected.  But the  mechanism that permits such stable,  chronic associations of 
ticks and their hosts have not been described. It seems likely that the pharma- 
cological armamentarium in saliva may specifically prevent antisalivary antibody 
production and antagonize chemical mediators of the host's inflammatory re- 
sponse.  Different hosts have evolved characteristic  methods for mediating im- 
mune and inflammatory responses. For example, rat and mouse mast cells contain 
important amounts of serotonin, whereas this amine may not be detectable in 
other  mammalian mast cells (42).  Some animals  release  more histamine than 
serotonin  after  platelet  aggregation  (43).  Asthma  in  guinea  pigs  is  mediated 
mostly by histamine, whereas leukotrienes predominate in the human disease 
(44). Stable host associations require that the tick match its host's defenses with 
an appropriate array of its own, suggesting that these defenses may fit as a "lock 
and key." These considerations support the idea that ticks, like other parasites, 
evade host reactions that  would cause  rejection,  and  that this adaptation  is a 
component of host specificity. 
Finally, the salivary components injected by ticks may promote invasion of the 
host by tick-borne pathogens. For example, by preventing macrophage activation 
and neutrophil activity (45), PGE~ would protect the pathogen during its initial 
phase of adaptation in the skin of a new host. L  dammini is the vector of human 
babesiosis and Lyme disease (46); coinjected saliva may facilitate transmission of 
these newly discovered agents of human disease. 
Summary 
Pilocarpine-induced saliva of the tick, Ixodes dammini, inhibited platelet aggre- 
gation triggered by ADP and collagen, as well as platelet-aggregation factor. In 
addition, we found apyrase activity (which degrades ATP and ADP to AMP and 
orthophosphate) and an anticoagulant. We showed the presence of prostaglandin 
E2 (PGE~) by bioassay and radioimmunoassay.  This saliva inhibited interleukin 2 
production by T  cell hybridomas, an activity consistent with that of PGE2.  A 
kininase was  demonstrated,  and  this  may counteract  the  algesia-  and  edema- 
promoting properties of PGE~.  Together,  these salivary components produce 342  PROPERTIES  OF  TICK  SALIVA 
antihemostatic, antiinflammatory, and immunosuppressive effects that may facil- 
itate feeding, as well as transmission of tick-borne pathogens. 
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E8.AI T  cell hybridomas, and for helpful advice. 
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